| scholarly article | Q13442814 |
| P50 | author | Carlos Suñé | Q55143545 |
| P2093 | author name string | García-Blanco MA | |
| P2860 | cites work | A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator | Q24338540 |
| Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein | Q24561778 | ||
| Composition of transcription factor B-TFIID | Q24564149 | ||
| Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 | Q24609153 | ||
| Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1 | Q24644981 | ||
| Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat | Q24655684 | ||
| In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor | Q24655901 | ||
| Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| New human gene encoding a positive modulator of HIV Tat-mediated transactivation | Q28187359 | ||
| Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein | Q28247468 | ||
| Direct interaction of human TFIID with the HIV-1 transactivator tat | Q28250314 | ||
| A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator | Q40650101 | ||
| Tat and the HIV-1 promoter | Q40835492 | ||
| Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. | Q40874297 | ||
| Does HIV-1 Tat induce a change in viral initiation rights? | Q40905875 | ||
| Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. | Q41079020 | ||
| HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure | Q41234955 | ||
| TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter | Q41724573 | ||
| Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex | Q42468497 | ||
| HIV-1 Tat Overcomes Inefficient Transcriptional Elongation in Vitro | Q42483631 | ||
| Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators | Q42491732 | ||
| Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. | Q42502083 | ||
| Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. | Q43447901 | ||
| HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
| Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression | Q44389543 | ||
| Fragments of the HIV-1 Tat protein specifically bind TAR RNA. | Q45148606 | ||
| Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity | Q45227677 | ||
| A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction | Q45256281 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
| Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes | Q45831871 | ||
| Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain? | Q45850138 | ||
| Factors (TAFs) required for activated transcription interact with TATA box-binding protein conserved core domain. | Q45934754 | ||
| Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor | Q46050449 | ||
| Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat | Q46674379 | ||
| Separation and characterization of factors mediating accurate transcription by RNA polymerase II. | Q47956947 | ||
| Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID | Q59070657 | ||
| Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells | Q64129425 | ||
| The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function | Q67782274 | ||
| An improved procedure for the purification of protein fused with glutathione S-transferase | Q67979721 | ||
| Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells | Q68504983 | ||
| A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation | Q68583028 | ||
| Mechanism of action of an acidic transcriptional activator in vitro | Q70113517 | ||
| HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors | Q28298100 | ||
| Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation | Q28303864 | ||
| Characterization of cDNAs encoding the polypyrimidine tract-binding protein | Q28609636 | ||
| An RNA polymerase II holoenzyme responsive to activators | Q29620210 | ||
| Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators | Q29620376 | ||
| HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
| HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 | ||
| Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein | Q33215947 | ||
| Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus | Q33575002 | ||
| A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat | Q33662926 | ||
| Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators | Q33930741 | ||
| Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression | Q33936851 | ||
| Trans-activation by HIV-1 Tat via a heterologous RNA binding protein | Q34156002 | ||
| Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region | Q34284937 | ||
| Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
| Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin | Q34631467 | ||
| Activation of class II gene transcription by regulatory factors is potentiated by a novel activity | Q34855093 | ||
| tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. | Q34975992 | ||
| Mechanism of action of regulatory proteins encoded by complex retroviruses | Q35403061 | ||
| HIV-1 Tat protein promotes formation of more-processive elongation complexes | Q35937536 | ||
| Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro | Q36398874 | ||
| Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells | Q36783325 | ||
| Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. | Q36802812 | ||
| trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. | Q36832567 | ||
| Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID. | Q36846156 | ||
| The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation | Q37506941 | ||
| Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter | Q37603547 | ||
| The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat | Q38320497 | ||
| The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence | Q38324797 | ||
| Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter | Q38325574 | ||
| Unusual structure of the human immunodeficiency virus type 1 trans-activation response element | Q38330641 | ||
| Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
| Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. | Q40045693 | ||
| ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. | Q40046433 | ||
| The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. | Q40066427 | ||
| Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat | Q40129795 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3098-3107 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors | |
| P478 | volume | 69 |
| Q33840754 | A re-examination of global suppression of RNA interference by HIV-1. |
| Q39717672 | A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription |
| Q24682560 | Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1 |
| Q24315725 | CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription |
| Q24806175 | COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells |
| Q28768535 | Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice |
| Q35872597 | Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm |
| Q24671522 | Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator |
| Q36724734 | Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression |
| Q24523183 | PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo |
| Q33769035 | Regulation of HIV-1 transcription |
| Q33684254 | Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes |
| Q24674098 | Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing |
| Q39872155 | Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat |
| Q24537527 | Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences |
| Q42848859 | TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation |
| Q24605302 | Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II |
| Q39069527 | Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication. |
Search more.